Marijuana and IBD: Challenging Decisions
Though patient use of cannabinoids for the treatment of IBD has increased, clinical decision making on whether to formally recommend it as treatment remains difficult.
Inflammatory Bowel Diseases (IBD)
Impact of IBD Medications on the SARS-CoV-2 Pandemic
Researchers explored the risk of SARS-CoV-2 infection with all classes of IBD medications and the impact of these medications on disease course.
Fecal DPP-4 Level May Be Biomarker for Inflammatory Bowel Disease
Researchers aimed to better elucidate the role of fDPP-4 levels as a biomarker of IBD activity and to correlate it with certain clinical parameters.
CDC Panel Recommends Resuming Use of J&J COVID-19 Vaccine
The United States should resume administering the Johnson & Johnson COVID-19 vaccine, a key advisory panel for the Centers for Disease Control and Prevention voted on Friday.
Does Autoimmune Disease Affect AE Rate With Immune Checkpoint Inhibition for Melanoma?
The safety and efficacy of immune checkpoint inhibition in patients with advanced melanoma with and without autoimmune disease was assessed.
Prevalence of Migraine, Severe Headache Up for Adults With IBD
Adults with inflammatory bowel disease (IBD) have a higher prevalence of migraine or severe headache.
Bacterial Swarmers Enriched During Intestinal Stress Help Heal Damage
Researchers aimed to determine the occurrence and consequence of bacterial swarming in humans and mice in the context of intestinal stress.
Immunosuppressive and Biologic Therapy in Expectant Fathers With IMIDs Not Linked to Adverse Birth Outcomes
Researchers examined the safety of exposure to immunosuppressive or biologic agents around the time of conception in expectant fathers with IMIDs.
Anxiety and Depression Common in Patients With Inflammatory Bowel Disease
Researchers assessed the prevalence of symptoms of anxiety and depression in adult patients with irritable bowel disease.
Upadacitinib Meets End Points in Ulcerative Colitis Trial
The U-ACCOMPLISH induction study evaluated the efficacy and safety of upadacitinib in 515 adults with moderate to severe ulcerative colitis.
- Loading...
Loading...
Next post in Inflammatory Bowel Diseases (IBD)
Loading... 
Loading...